Pursuant to Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BMW Industries' board, at its May 16, 2025 meeting, approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025. Consolidated revenue from operations rose about 5% to Rs. 62,862.08 lakhs (from Rs. 59,818.74 lakhs), while consolidated net profit grew roughly 17% to Rs. 7,484.30 lakhs (from Rs. 6,379.81 lakhs), lifting EPS to Rs. 3.33 vs Rs. 2.83. Standalone PAT came in at Rs. 6,359.51 lakhs, up about 8% YoY. The board recommended a final dividend of Rs. 0.43 (43%) per equity share, translating to an estimated payout of around Rs. 967.87 lakhs, subject to shareholder approval. Statutory auditor Lodha & Co LLP issued an unmodified opinion on the results. The board also appointed MKB & Associates as Secretarial Auditor for a five-year term from FY26 to FY30. The scheme to merge two wholly-owned subsidiaries (BMWISIL and Nippon Cryo) with the parent, effective April 1, 2024, remains pending before NCLT. Pending income tax appeals of Rs. 346.24 lakhs also remain unresolved.
Positive for shareholders — the company posted healthy profit growth, declared a meaningful dividend, and received a clean audit report, signaling stable operations. Investors should watch the pending NCLT merger scheme and open tax disputes as potential overhangs.